• 1. Urine metabolomics reveals new insights into hyperlipidemia and the therapeutic effect of rhubarb
  Hua Chen,Bin Yuan,Hua Miao,Yi Tan,Xu Bai,Ying-Yong Zhao,Yun Wang Anal. Methods 2015 7 3113
• 2. Systems biology analysis of hepatitis C virus infection reveals the role of copy number increases in regions of chromosome 1q in hepatocellular carcinoma metabolism
  Ibrahim E. Elsemman,Adil Mardinoglu,Saeed Shoaie,Taysir H. Soliman,Jens Nielsen Mol. BioSyst. 2016 12 1496
• 3. Metabolomics study reveals the alteration of fatty acid oxidation in the hearts of diabetic mice by empagliflozin
  Yingwei Zhang,Zeyu Zhang,Chundi Li,Donge Tang,Yong Dai Mol. Omics 2022 18 643
• 4. Metabolomics study reveals the alteration of fatty acid oxidation in the hearts of diabetic mice by empagliflozin
  Yingwei Zhang,Zeyu Zhang,Chundi Li,Donge Tang,Yong Dai Mol. Omics 2022 18 643
• 5. Metabolomics for improved treatment monitoring of phenylketonuria: urinary biomarkers for non-invasive assessment of dietary adherence and nutritional deficiencies
  Jennifer Wild,Meera Shanmuganathan,Mika Hayashi,Murray Potter,Philip Britz-McKibbin Analyst 2019 144 6595

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Acyl carnitines
• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Fatty acid esters Acyl carnitines

Comprehensive Guide to Propionyl-L-carnitine (CAS No. 17298-37-2): Benefits, Mechanisms, and Applications

Propionyl-L-carnitine (PLC), with the CAS number 17298-37-2, is a naturally occurring derivative of L-carnitine, a compound essential for energy metabolism. This modified form combines L-carnitine with a propionyl group, enhancing its bioavailability and therapeutic potential. PLC has gained significant attention in recent years due to its role in cardiovascular health, metabolic support, and athletic performance. Researchers and health enthusiasts alike are increasingly searching for terms like "Propionyl-L-carnitine benefits," "PLC for heart health," and "17298-37-2 supplement uses," reflecting growing interest in its applications.

The primary mechanism of Propionyl-L-carnitine revolves around its ability to optimize fatty acid oxidation, particularly in tissues with high energy demands, such as the heart and skeletal muscles. Unlike standard L-carnitine, PLC’s propionyl moiety provides additional metabolic flexibility, making it a preferred choice for conditions like peripheral artery disease (PAD) and chronic fatigue. Recent studies highlight its potential to improve endothelial function, a hot topic in cardiovascular research, as users frequently search for "natural ways to boost circulation" and "PLC for vascular health."

In the realm of sports nutrition, Propionyl-L-carnitine is often compared to other performance enhancers like creatine or beta-alanine. Searches for "PLC vs. L-carnitine for endurance" or "best carnitine form for athletes" underscore its relevance. PLC’s dual action—supporting energy production while reducing oxidative stress—makes it a standout ingredient in pre-workout formulas. Additionally, its neuroprotective properties are gaining traction, with queries like "PLC for cognitive function" emerging in nootropic discussions.

From a biochemical perspective, the CAS no. 17298-37-2 identifies Propionyl-L-carnitine as a distinct entity with unique pharmacokinetics. Its molecular structure allows for efficient cellular uptake, a feature often explored in peer-reviewed journals. This specificity aligns with the rise in "targeted nutrient delivery" as a wellness trend. Furthermore, PLC’s synergy with antioxidants like coenzyme Q10 is frequently cited, addressing search trends such as "combining PLC with CoQ10."

Quality and sourcing are critical for Propionyl-L-carnitine efficacy. Consumers increasingly seek "PLC purity standards" and "17298-37-2 testing methods," emphasizing the need for transparency in nutraceutical manufacturing. Regulatory-compliant production ensures optimal potency, a point of interest for professionals navigating "clinical-grade PLC supplements." As research evolves, PLC’s applications in age-related metabolic decline and insulin sensitivity continue to expand, cementing its status as a multifaceted therapeutic agent.

• 31023-24-2(3-Methylbutyrylcarnitine)
• 102636-82-8(Glutaroyl carnitine)
• 3040-38-8(L-Acetylcarnitine)
• 14992-62-2(Acetylcarnitine)
• 31023-25-3(3-((2-Methylbutanoyl)oxy)-4-(trimethylammonio)butanoate)
• 503601-25-0(ethyl 2-morpholin-2-ylacetate)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)